Illness	Number of cases
Obstructive uropathy and refluxuropathy - Hydronephrosis in obstruction by renal and ureteral calculi - Hydronephrosis in obstruction by ureteral calculi (N13.21)	398
Malignant neoplasm of bladder - Malignant neoplasm of overlapping sites of bladder (C67.8)	269
Hyperplasia of prostate (N40)	151
Unspecified haematuria (R31)	150
Calculus of kidney and ureter - Calculus of kidney (N20.0)	141
Other disorders of urinary system - Urinary tract infection site not specified (N39.0)	139
Calculus of kidney and ureter - Calculus of ureter (N20.1)	124
Obstructive and reflux uropathy (N13.3)	110
Acute tubulo-interstitial nephritis (N10)	80
Malignant neoplasm of prostate (C61)	66

Top 10 treatments

Treatment	Number
Injection or administration of medicines into the urinary bladder (8-132.2)	838
X-rays of the kidney and urinary tract with contrast medium (3-13d.5)	604
Insertion, exchange or removal of a ureteral stent (8-137.00)	405
Surgical incision, removal or destruction of diseased tissue in the urinary bladder, with access through the urethra (5-573.40)	312
Insertion, exchange or removal of a ureteral stent (8-137.10)	253
Examination of the ureter by endoscopy (1-665)	232
X-rays of the kidney and urinary tract with contrast medium (3-13d.6)	197
Surgical creation of a connection between the urinary bladder and skin of the abdomen for artificial urinary drainage (5-572.1)	167
Surgical removal or destruction of prostatic tissue through the urethra (5-601.1)	163
Computed tomography (CT) of the abdomen without contrast medium (3-207)	153

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 2200

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

Quality of participation in the Disease Management Programme (DMP)
No participation

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)
No participation

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
22	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
18	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
17	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility

Accessibility information

General information

Research & teaching

Job	Explanation
Lectureships / teaching posts at colleges and universities
Student training (clinical traineeship / internship year)
Editors of scientific journals/textbooks
Doctoral supervision

Training

No.	Training in other healing professions	Comment
HB01	Nurse and health care worker (m/f)
HB03	Physical therapist / physiotherapist (m/f)	In Zusammenarbeit mit Fachschulen
HB19	Nursing professionals
HB02	Health and paediatric nurse (m/f)
HB07	Surgical technical assistant (m/f)
HB18	Emergency paramedics (m/f) (training period 3 years)	Im Rahmen der Ausbildung in div. Abteilungen.
HB06	Occupational therapist (m/f)	In Zusammenarbeit mit Fachschulen.